PubRank

E Holmgren

Author PubWeight™ 48.52‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer. J Clin Oncol 2001 4.97
2 Minimally important differences were estimated for the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) instrument using a combination of distribution- and anchor-based approaches. J Clin Epidemiol 2005 4.29
3 A synthetic IgG-binding domain based on staphylococcal protein A. Protein Eng 1989 3.31
4 Phase Ib trial of intravenous recombinant humanized monoclonal antibody to vascular endothelial growth factor in combination with chemotherapy in patients with advanced cancer: pharmacologic and long-term safety data. J Clin Oncol 2001 1.58
5 Rhizobium meliloti anthranilate synthase gene: cloning, sequence, and expression in Escherichia coli. J Bacteriol 1989 1.47
6 A gene fusion system for generating antibodies against short peptides. Gene 1987 1.42
7 Cooperative effects by the initiation codon and its flanking regions on translation initiation. Gene 2001 1.33
8 Characterization of a succinate dehydrogenase complex solubilized from the cytoplasmic membrane of Bacillus subtilis with the nonionic detergent Triton X-100. J Bacteriol 1979 1.29
9 Characterization of succinic dehydrogenase mutants of Bacillus subtilis by crossed immunoelectrophoresis. J Bacteriol 1978 1.27
10 The Reaction Level Scale (RLS85). Manual and guidelines. Acta Neurochir (Wien) 1988 1.24
11 Efficient secretion and purification of human insulin-like growth factor I with a gene fusion vector in Staphylococci. Nucleic Acids Res 1985 1.18
12 Role of heme in synthesis and membrane binding of succinic dehydrogenase in Bacillus subtilis. J Bacteriol 1979 1.14
13 A comparison of the Glasgow Coma Scale and the Reaction Level Scale (RLS85). J Neurosurg 1988 1.05
14 Co-existing structures of an mRNA stability determinant. The 5' region of the Escherichia coli and Serratia marcescens ompA mRNA. J Mol Biol 1993 1.02
15 Expression of human insulin-like growth factor I in bacteria: use of optimized gene fusion vectors to facilitate protein purification. Biochemistry 1987 0.98
16 Evaluation of the pain suppressive effect of different frequencies of peripheral electrical stimulation in chronic pain conditions. Acta Orthop Scand 1976 0.97
17 Production of specific antibodies against protein A fusion proteins. EMBO J 1986 0.97
18 On acupuncture analgesia and the mechanism of pain. Am J Chin Med (Gard City N Y) 1975 0.96
19 Isolation of cDNA sequences coding for a part of human tissue plasminogen activator. Proc Natl Acad Sci U S A 1983 0.93
20 Dual affinity fusion approach and its use to express recombinant human insulin-like growth factor II. Proc Natl Acad Sci U S A 1989 0.91
21 A recombinant Escherichia coli heat-stable enterotoxin (STa) fusion protein eliciting anti-STa neutralizing antibodies. FEMS Microbiol Lett 1991 0.90
22 Bacillus subtilis mutant with temperature-sensitive net synthesis of phosphatidylethanolamine. J Bacteriol 1977 0.88
23 Synthesis and secretion of a fibrinolytically active tissue-type plasminogen activator variant in Escherichia coli. Gene 1991 0.88
24 A large convexity meningioma followed by liquorrhoea from a nasal encephalocele. A case report. Acta Neurochir (Wien) 1981 0.87
25 Current reporting of responsiveness in acute cerebral disorders. A survey of the neurosurgical literature. J Neurosurg 1988 0.86
26 Regulation of tryptophan genes in Rhizobium leguminosarum. J Bacteriol 1982 0.86
27 Human immunodeficiency viral protease is catalytically active as a fusion protein: characterization of the fusion and native enzymes produced in Escherichia coli. Arch Biochem Biophys 1990 0.86
28 Structure of a combination of Functional Independence Measure and Instrumental Activity Measure items in community-living persons: a study of individuals with cerebral palsy and spina bifida. Arch Phys Med Rehabil 1996 0.82
29 Post-operative thromboembolism in neurosurgery. A study on the prophylactic effect of calf muscle stimulation plus dextran compared to low-dose heparin. Acta Neurochir (Wien) 1986 0.81
30 Electro-acupuncture. Effect on pain threshold measured with electrical stimulation of teeth. Brain Res 1973 0.81
31 Enhanced immunogenicity of recombinant peptide fusions containing multiple copies of a heterologous T helper epitope. Eur J Immunol 1990 0.80
32 Fusion protein approach to improve the crystal quality of cytochrome bo(3) ubiquinol oxidase from Escherichia coli. Biochim Biophys Acta 2000 0.80
33 Characterization of an extended form of recombinant human insulin-like growth factor II. J Biol Chem 1991 0.79
34 Thrombin and H64A subtilisin cleavage of fusion proteins for preparation of human recombinant parathyroid hormone. J Protein Chem 1991 0.79
35 Fibrinopeptide A and fibrinogen fragment B beta 15-42 and their relation to the operative trauma and post-operative thromboembolism in neurosurgical patients. Acta Neurochir (Wien) 1987 0.78
36 An evaluation of different enzymatic cleavage methods for recombinant fusion proteins, applied on des(1-3)insulin-like growth factor I. J Protein Chem 1992 0.78
37 Fusions to the 5' end of a gene encoding a two-domain analogue of staphylococcal protein A. J Biotechnol 1992 0.77
38 Expression and characterization of a recombinant human parathyroid hormone secreted by Escherichia coli employing the staphylococcal protein A promoter and signal sequence. J Biol Chem 1990 0.76
39 Assessment of responsiveness in acute cerebral disorders. A multicentre study on the reaction level scale (RLS 85). Acta Neurochir (Wien) 1988 0.76
40 On-line strategies for determining trace levels of nitroaromatic explosives and related compounds in water. J Chromatogr A 2006 0.76
41 Three human interferon-alpha 2 subvariants disclose structural and functional differences. Eur J Biochem 1990 0.75
42 [Low frequent transcutaneous electrical stimulation for pain relief during labor]. Lakartidningen 1976 0.75
43 Synchronization and desynchronization in the thalamus of the unanaesthetized decorticate cat. Electroencephalogr Clin Neurophysiol 1971 0.75
44 Changes in synaptic function induced by blockage of axonal transport in the rabbit optic pathway. Brain Res 1978 0.75
45 Increase of pain threshold as a function of conditionsing electrical stimulation. An experimental study with application to electro-acupuncture for pain suppression. Am J Chin Med (Gard City N Y) 1975 0.75
46 Weight loss and cerebrospinal-fluid leptin in obesity. Lancet 1998 0.75
47 Purification and characterization of recombinant human insulin-like growth factor II (IGF-II) expressed as a secreted fusion protein in Escherichia coli. Biotechnol Appl Biochem 1991 0.75
48 Respiratory depression after cimetidine reversed by physostigmine. Intensive Care Med 1982 0.75
49 Electro-acupuncture and pain threshold. Lancet 1973 0.75
50 Differential stability of recombinant human insulin-like growth factor II in Escherichia coli and Staphylococcus aureus. J Biotechnol 1990 0.75
51 The relationship of hallucinations to the depth structures of the temporal lobe. Acta Neurochir (Wien) 1977 0.75
52 Acute head injuries: cooperative efforts in clinical assessment. J Neurosurg 1981 0.75
53 On a free autologous graft of the greater omentum for spinal CSF drainage. Z Kinderchir 1986 0.75
54 Thalamo-cortical rhythmicity during reversible visual deafferentation. Acta Physiol Scand 1970 0.75
55 [Prevention of thrombosis using heparin in neurosurgical intervention]. Lakartidningen 1980 0.75
56 [Surgical education in the Swedish neurosurgery - has the postgraduate training fulfilled the expectations?]. Lakartidningen 1982 0.75
57 A method for the evaluation of the efficiency of signal sequences for secretion and correct N-terminal processing of human parathyroid hormone produced in Escherichia coli. Anal Biochem 1992 0.75
58 Localized thalamic rhythmicity induced by spinal and cortical lesions. Electroencephalogr Clin Neurophysiol 1971 0.75
59 Letter: Electro-acupuncture and pain threshold. Lancet 1973 0.75
60 Translocation and processing of various human parathyroid hormone peptides in Escherichia coli are differentially affected by protein-A-signal-sequence mutations. Eur J Biochem 1994 0.75